Skip to content

Investigating the Effectiveness of E-CBTi Compared to Pharmaceutical Interventions in Treating Insomnia

Insomnia

Insomnia is defined as the inability to fall asleep or stay asleep at night and it is one of the most prevalent sleep disorders that can have deleterious impacts on health and this population's quality of life. Currently, both pharmaceutical interventions (trazodone) and cognitive behavioral therapy (CBTi) are widely used to treat patients with insomnia. Although CBTi has been efficacious in many patients, multitude of barriers for receiving treatment such as its limited availability of therapists, high costs and long wait times challenge its ability in sufficiently meeting the population's health needs and demands. To improve the delivery of CBT, electronically delivered CBTi (e-CBTi) has been developed as an accessible and effective alternative intervention for improving sleep outcomes in patients with insomnia. While evidence suggest that e-CBTi is effective when compared to placebos/waitlist control, evidence comparing guided e-CBTi to pharmaceutical interventions is still insufficient and needs further exploration.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* At least 18 years of age at the start of the study
* Non-organic insomnia
* Difficulty initiating, and/or maintaining sleep for ≥ 30 minutes and
* Use of sleep-promoting medication at least three nights per week for at least 3 months
* Ability to speak and read English
* Consistent and reliable access to the internet.

Exclusion Criteria:

* Presence of another untreated sleep disorder
* Alcohol or substance use disorder
* Ongoing CBT
* Non-assessed or untreated clinically significant somatic or mental symptoms or illnesses
* Other sleep disorders that could explain current insomnia symptoms or interfere with or be worsened by e-CBTi
* Pregnancy

Study Location

Queen's University
Queen's University
Kingston, Ontario
Canada

Contact Study Team

Backup Contact

Nazanin Alavi, MD FRCPC

Primary Contact

Nazanin Alavi, MD FRCPC

[email protected]
6135443310
Study Sponsored By
Queen's University
Participants Required
More Information
Study ID: NCT05125146